User profiles for Carlos F. Uribe

Carlos Uribe

BC Cancer Research Institute
Verified email at bccrc.ca
Cited by 1082

Enhancing Treatment Efficacy of 177Lu-PSMA-617 with the Conjugation of an Albumin-Binding Motif: Preclinical Dosimetry and Endoradiotherapy Studies

HT Kuo, H Merkens, Z Zhang, CF Uribe… - Molecular …, 2018 - ACS Publications
We designed and evaluated a novel albumin-binder-conjugated 177 Lu-PSMA-617 derivative,
177 Lu-HTK01169, with an extended blood retention time to maximize the radiation dose …

[HTML][HTML] Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs

…, CF Ramogida, A Celler, A Rahmim, CF Uribe - Theranostics, 2022 - ncbi.nlm.nih.gov
Theranostics is an emerging paradigm that combines imaging and therapy in order to personalize
patient treatment. In nuclear medicine, this is achieved by using radiopharmaceuticals …

177Lu-labeled albumin-binder–conjugated PSMA-targeting agents with extremely high tumor uptake and enhanced tumor-to-kidney absorbed dose ratio

…, CF Uribe, H Merkens, C Zhang, F Bénard - Journal of Nuclear …, 2021 - Soc Nuclear Med
The use of an albumin binder has been shown to improve tumor uptake of prostate-specific
membrane antigen (PSMA)–targeting radiotherapeutic agents. The aim of this study was to …

Machine learning in nuclear medicine: part 1—introduction

CF Uribe, S Mathotaarachchi, V Gaudet… - Journal of Nuclear …, 2019 - Soc Nuclear Med
This article, the first in a 2-part series, provides an introduction to machine learning (ML) in a
nuclear medicine context. This part addresses the history of ML and describes common …

[HTML][HTML] Accuracy of 177Lu activity quantification in SPECT imaging: a phantom study

CF Uribe, PL Esquinas, J Tanguay, M Gonzalez… - EJNMMI physics, 2017 - Springer
Background The aim of the study is to assess accuracy of activity quantification of 177 Lu
studies performed according to recommendations provided by the committee on Medical …

[HTML][HTML] What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney …

…, H Merkens, R Tan, A Roxin, CF Uribe, F Bénard - Theranostics, 2022 - ncbi.nlm.nih.gov
The aim of this study was to investigate the effect of replacing Glu in the Lys-urea-Glu PSMA-targeting
pharmacophore of [68 Ga] Ga-HTK03041 with a close analog on the uptake of …

[HTML][HTML] Determination of gamma camera calibration factors for quantitation of therapeutic radioisotopes

W Zhao, PL Esquinas, X Hou, CF Uribe, M Gonzalez… - EJNMMI physics, 2018 - Springer
Background Camera calibration, which translates reconstructed count map into absolute
activity map, is a prerequisite procedure for quantitative SPECT imaging. Both planar and …

[HTML][HTML] Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss

…, A Ortiz, S Zhang, F Bénard, R Dodhia, CF Uribe… - Computers in Biology …, 2023 - Elsevier
Purpose Automatic and accurate segmentation of lesions in images of metastatic castration-resistant
prostate cancer has the potential to enable personalized radiopharmaceutical …

[HTML][HTML] Radiomics-guided radiation therapy: opportunities and challenges

…, DE Hyde, S Thomas, J Wu, CF Uribe… - Physics in Medicine …, 2022 - iopscience.iop.org
Radiomics is an advanced image-processing framework, which extracts image features and
considers them as biomarkers towards personalized medicine. Applications include disease …

Positron emission tomography imaging of the gastrin-releasing peptide receptor with a novel bombesin analogue

J Lau, E Rousseau, Z Zhang, CF Uribe, HT Kuo… - ACS …, 2019 - ACS Publications
The gastrin-releasing peptide receptor (GRPR), a G protein-coupled receptor, is overexpressed
in solid malignancies and particularly in prostate cancer. We synthesized a novel …